2BBBullish & Bearish
Day One Biopharmaceuticals, Inc. (DAWN) trades on NASDAQ. It operates in the Healthcare sector, Biotechnology industry. Its current 2BB score is 0 out of 100.
Day One Biopharmaceuticals, Inc.’s current 2BB score is 0 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 0 | Strongly Weakening |
| Financial strength | 0 | Very Weak |
| Quality | 0 | Very Weak |
| Risk | 0 | Very Low |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-10-28 | — | -0.1723 | — | $62.89M |
| 2026-07-29 | — | -0.1859 | — | $58.27M |
| 2026-06-17 | — | -0.4284 | — | $58.99M |
| 2026-02-24 | -0.21 | -0.1549 | $53.72M | $49.54M |